AAMU
NEO icon

Amundi Asset Management US’s NeoGenomics NEO Stock Holding History

Amundi Asset Management US’s Portfolio NEO Stock Details NEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-8,200
Closed -$103K – 1671
2018
Q4 		$103K Buy
+8,200
New +$122K ﹤0.01% 1503

Other funds holding NEO

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return
EAM
Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return
Brown Advisory
Brown Advisory Baltimore, Maryland $64.6B AUM 18.98% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
CTA
Carillon Tower Advisers St. Petersburg, Florida $16.4B AUM 64.75% 1-Year Est. Return
EA
Emerald Advisers Leola, Pennsylvania $4.25B AUM 141.71% 1-Year Est. Return
EMFAT
Emerald Mutual Fund Advisers Trust Leola, Pennsylvania $2.85B AUM 140.52% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

Amundi Asset Management US's NEO Position: Q1 2019 in Review

Amundi Asset Management US sold out of NeoGenomics (NEO) in Q1 2019, closing a stake of 8,200 shares — an estimated $103K sold.

Amundi Asset Management US first reported a position in NEO in Q4 2018 and held it in 1 quarter. The position peaked at $103K in Q4 2018. 235 funds tracked by Wall St. Rank hold NEO as of Q1 2019.

  • Amundi Asset Management US reported no remaining NeoGenomics position as of Q1 2019 after selling out during the quarter.
  • Amundi Asset Management US sold 8,200 NeoGenomics shares in Q1 2019, an estimated $103K.
  • Amundi Asset Management US first reported a position in NeoGenomics in Q4 2018 and held it in 1 quarter.
  • Amundi Asset Management US's NeoGenomics position peaked at $103K in Q4 2018.
  • 235 funds tracked by Wall St. Rank held NeoGenomics as of Q1 2019.

Based on Amundi Asset Management US's 13F filing for Q1 2019, filed 13 May 2019.